Back
argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 20 jun 2018 - 07:00
- Statutory name argenx SE
- Title argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris
Related downloads
| 201806200000000003_argenx reports interim data from first cohort of Phase 2 proof-of-concept clinical trial of efgartigimod for the treatment of pemphigus vulgaris.pdf |
Date last update: 19 November 2018
Share information